Entwicklung neointimaler Matrix nach Einheilen moderner Prothesen: Vergleich zwischen ePTFE und Dacron

Zusammenfassung

Hintergrund: In der Therapie der peripheren arteriellen Verschlusskrankheit bestehen insbesondere beim Einsatz alloplastischer Materialien Unzulänglichkeiten bzgl. der Thrombogenität und der biologischen Compliance. In den 1960er-Jahren versuchte Sparks durch Verwendung eingewachsener Prothesen, die Vorteile der alloplastischen Prothese mit denen eines autologen Gefäßersatzes zu kombinieren. Eine ausgeprägte myointi­male Hyperplasie fehlte, aber neben Infektionen waren vor allem die aneurysmatische Aufweitung der implantierten Prothesen limitierende Faktoren in der klinischen Anwendung. Material und Methoden: Im Rahmen eines Tierversuches an Hunden wurde in der vorliegen­den Studie das Einwachsverhalten moderner ­Pro­thesenmaterialien ohne Anschluss an das ­Gefäßsystem bzgl. der Dicke der Neointima und des prozentualen Anteils von glatten Muskelzellen untersucht. Ergebnisse: Hierbei zeigte sich, dass die Dicke der Neointima in Dacronprothesen stärker zunahm als in PTFE-Prothesen mit einem Peak am 70. Tag (p = 0,022), zusätzlich zeigte sich ein signifikant höherer prozentualer Anteil glatter Muskelzellen in Dacronprothesen als in PTFE-Prothesen nach 44 und 58 Tagen (p = 0,008; p = 0,036). Schlussfolgerung: PTFE-Prothesen sollten daher aufgrund der geringeren eingewachsenen Matrix sowie des geringeren Anteils an glatten Muskelzellen bei peripheren arteriellen Gefäßrekonstruktionen den Vorzug erhalten.

Abstract

Background: In the therapy for peripheral arterial occlusive disease there remain inadequacies in the use of alloplastic material concerning thrombogenicity and biological compliance. In the 1960s, Sparks tried to combine the advantages of alloplastic prostheses with those of autologous reconstructions by using incorporated prostheses. No extensive myointimal hyperplasia was noted, but besides infections aneurysmatic dilatation were limiting factors in clinical practice. Material and Methods: The incorporation of modern alloplastic prostheses without connection to circulation concerning the thickness of neo­intima as well as the percentage of smooth muscle cells was examined in a dog model. Results: The thickness of the neointima increased significantly in Dacron grafts with a peak on day 70 (p = 0.022), additionally a significantly greater percentage of smooth muscle cells was noted in Dacron grafts after 44 and 58 days (p = 0.008, p = 0.036). Conclusion: Due to the decreased thickness of the incorporating matrix as well as the lower percent­age of smooth muscle cells, PTFE grafts should be preferred for peripheral arterial revascularisa­tion.

Schlüsselwörter

Bypass-Material - Gefäßchirurgie

Key words

bypass material - vascular surgery

Literatur

• 1 Veith F J, Gupta S K, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.  J Vasc Surg. 1986;  3 104-114
• 2 Cacciatore R, Inderbitzi R, Stirnemann P. Five years experience with ­infra-inguinal arterial reconstruction: a comparison of venous with PTFE bypass.  Vasa. 1992;  21 171-176
• 3 Evans L E, Webster M W, Brooks D H et al. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight- month follow-up.  Surgery. 1981;  89 16-22
• 4 McAuley C E, Steed D L, Webster M W. Seven-year follow-up of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts.  Ann Surg. 1984;  199 57-60
• 5 Prendiville E J, Yeager A, O’Donnell Jr T F et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft.  J Vasc Surg. 1990;  11 517-524
• 6 Quinones-Baldrich W J, Prego A A, Ucelay-Gomez R et al. Long-term ­results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience.  J Vasc Surg. 1992;  16 209-217
• 7 Solaković E, Totić D, Solaković S. Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft.  Bosn J Basic Med Sci. 2008;  8 367-372
• 8 Luther B, Balzer K M, Reinecke P et al. Homologous vein transplantation in cruropedal arterial reconstruction.  Chirurg. 2004;  75 153-159
• 9 Balzer K M, Luther B, Sandmann W et al. Donor-specific sensitization by cadaveric venous allografts used for arterial reconstruction in peripheral arterial occlusive vascular disease.  Tissue Antigens. 2004;  64 13-17
• 10 Kent K C, Whittemore A D, Mannick J A. Short-term and midterm results of an all-autogenous tissue policy for infrainguinal reconstruction.  J Vasc Surg. 1989;  9 107-120
• 11 Losi P, Lombardi S, Briganti E. Luminal surface microgeometry affects platelet adhesion in small-diameter synthetic grafts.  Biomaterials. 2004;  25 4447-4455
• 12 Sparks C H. Tissue Dies.  Surgical Forum. 1968;  19 5-56
• 13 Sparks C H. Autogenous grafts made to order.  Ann Thorac Surg. 1969;  8 104-113
• 14 Sparks C H. Die-grown reinforced arterial grafts: observations on long-term animal grafts and clinical experience.  Ann Surg. 1970;  172 787-794
• 15 Hallin R W, Sweetman W R. The Sparks’ mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates.  Am J Surg. 1976;  132 221-223
• 16 Stockmann U, Kleine H O, Hepp W. [Experiences with the Sparks-prosthesis in the periphery (author’s transl)].  Thoraxchir Vask Chir. 1975;  23 742-744
• 17 Kretschmer G, Polterauer P, Wagner O et al. [Sparks grafts as arterial substitutes in the femoro-popliteal region with a postoperative follow-up of up to 54 months].  Helv Chir Acta. 1981;  48 243-250
• 18 Christenson J T, Eklof B. Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass.  Br J Surg. 1979;  66 514-517
• 19 Guidoin R, Thevenet A, Noel H P et al. [The Sparks-Mandril arterial prosthesis. An ingenious concept, a total failure. What can we learn from it?].  J Mal Vasc. 1984;  9 277-283
• 20 Loose D ABF. Kriterien zur Prüfung einer kombinierten Gefäßprothese: Ergebnisse experimenteller, klinischer und morphologischer Unter­suchungen. Stuttgart: Thieme; 1980
• 21 Borchard F, Kremer K, Loose D A. [Light- and electronmicroscopic findings in nine auto-alloplastic vascular grafts (Sparks-Mandril) (author’s transl)].  Thoraxchir Vask Chir. 1975;  23 83-97
• 22 Brieler H S, Thiede A, Muller-Wiefel H et al. [Histological and histochemical evaluation of the cellular infiltration of s. c. implanted sparks prothesis. Experiments on rats (authors transl)].  Thoraxchir Vask Chir. 1975;  23 270-273
• 23 Brossollet L J. Mechanical issues in vascular grafting: A review.  Int J Artif Organs. 1992;  15 579-584
• 24 Salacinski H J, Goldner S, Giudiceandrea A. The mechanical behaviour of vascular grafts: A review.  J Biomater Appl. 2001;  15 241-278
• 25 Zidi M, Cheref M. Mechanical analysis of a prototype of small diameter vascular prosthesis: Numerical simulations.  Comput Biol Med. 2003;  33 65-75
• 26 Rhee K, Tarbell J M. A study of the wall shear rate distribution near the end-to-end anastomosis of a rigid graft and a compliant artery.  J Biomech. 1994;  27 329-338
• 27 Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium.  Surgery. 1978;  84 498-504
• 28 Bhattacharya V, McSweeney P A, Shi O et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34 bone marrow cells.  Blood. 2000;  95 581-585
• 29 Griese D P, Ehsan A, Melo L G et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.  Circulation. 2003;  108 2710-2715
• 30 Wang Z G, Zhang H, Pu L Q et al. Can endothelial seeding enhance ­patency and inhibit neointimal hyperplasia? Experimental studies and clinical trial of endothelial seeded venous prostheses.  Int Angiol. 2000;  19 259-269
• 31 Deutsch M, Meinhart J, Zilla P et al. Clinical autologous in vitro endo­thelialisation of infrainguinal ePTFE grafts: Long term experience in 318 patients.  J Vasc Surg. 2009;  49 352-362
• 32 Davies M G, Hagen P O. Pathobiology of intimal hyperplasia.  Br J Surg. 1994;  81 1254-1269
• 33 Lehr H A, Mankoff D A, Corwin D et al. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer.  J Histochem Cytochem. 1997;  45 1559-1565
• 34 Kannan R Y, Salacinski H J, Butler P E et al. Current status of prosthetic bypass grafts: a review.  J Biomed Mater Res B Appl Biomater. 2005;  74 570-581
• 35 Huang P, Hawthorne W J, Peng A et al. Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model.  Am J Surg. 2001;  181 492-498
• 36 Bauriedel G, Schluckebier S, Hutter R et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis.  Arterioscler Thromb Vasc Biol. 1998;  18 1132-1139
• 37 Virmani R, Kolodgie F D, Dake M D et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in ­canine iliofemoral arteries.  J Vasc Interv Radiol. 1999;  10 445-456
• 38 Yu H, Dai W, Yang Z et al. Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo.  J Vasc Surg. 2003;  38 557-563